Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Respiratory Diseases Surge While Immunizations Wane
2025
· Children's Hospital Colorado
The newsletter article highlights a rise in respiratory diseases like RSV, COVID-19, and influenza in Colorado due to low vaccination rates. It describes how children …
Ask aRCie
Digital Toolkit for the Maternal RSV Vaccine
This is a digital toolkit for the maternal RSV vaccine, which helps protect babies from severe RSV disease. It includes decision guides and videos about …
Interim Immunization Protocol (RSV)
2025
· Oregon Health Authority
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant …
Respiratory Viruses Vaccine Recommendations
This site provides vaccine recommendations for respiratory viruses like COVID-19, flu, and RSV. It describes who should get vaccinated and when. Everyone 6 months and …
Childhood Vaccines: What Immunizations Are Recommended and At What Age?
2025
· NewYork-Presbyterian
This article explains the importance of childhood vaccines and following the recommended immunization schedule. Dr. Melissa Stockwell, a pediatric expert, assures that vaccines are safe …
Making Vaccine Decisions During Pregnancy: What to Know
This newsletter describes the importance of four vaccines during pregnancy: influenza, COVID-19, Tdap, and RSV. These vaccines protect both mothers and babies from severe diseases. …
Respiratory Syncytial Virus (RSV): Advisory Committee on Immunization Practices (ACIP) Recommendations
2024
· Johns Hopkins University
The Advisory Committee on Immunization Practices (ACIP) provides guidelines for preventing Respiratory Syncytial Virus (RSV). Infants up to 8 months should get a dose of …
Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization
2024
· University of Minnesota
This news brief describes the effectiveness of nirsevimab, a monoclonal antibody drug, in protecting children under 5 from RSV. The drug is 89% effective against …
Studies Show More Promising Results for RSV Drug Nirsevimab
2024
· University of Minnesota
This blog post describes two studies showing that the RSV drug nirsevimab is effective in protecting infants from respiratory syncytial virus. The first study found …
Should You Get an RSV Vaccine?
2025
· Yale University
This news article describes the importance of getting an RSV vaccine, especially for older adults and babies. RSV is a virus that can cause serious …